Ben Tran

Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis.

Daniel V Araujo, J Connor Wells, Aaron R Hansen, Nazli Dizman, Sumanta K Pal, Benoit Beuselinck, Frede Donskov, Chun L Gan, Flora Yan, Ben Tran, Christian K Kollmannsberger, Guillermo de Velasco, Takeshi Yuasa, M Neil Reaume, D Scott Ernst, Thomas Powles, Georg A Bjarnason, Toni K Choueiri, Daniel YC Heng, Shaan Dudani

Journal article  |  2021  |  Journal of Geriatric Oncology

OBJECTIVE: Older adults with metastatic renal cell carcinoma(mRCC) are underrepresented in immune-checkpoint inhibitor(ICI) regist..

A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol

David Pryor, Mathias Bressel, Nathan Lawrentschuk, Ben Tran, Jennifer Mooi, Jeremy Lewin, Arun Azad, Duncan Colyer, Nitika Neha, Mark Shaw, Sarat Chander, Paul Neeson, Daniel Moon, Katharine Cuff, Simon Wood, Declan G Murphy, Shahneen Sandhu, Sherene Loi, Shankar Siva

Journal article  |  2021  |  Contemporary Clinical Trials Communications

Background: The management of oligometastatic clear cell renal cell carcinoma (ccRCC) varies widely, ranging from observation to r..

The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).

Andrew Lachlan Schmidt, Wanling Xie, Chun Loo Gan, Connor Wells, Shaan Dudani, Frede Donskov, Camillo Porta, Cristina Suarez, Bernadett Szabados, Lori Wood, Jose Manuel Ruiz Morales, Ben Tran, Georg A Bjarnason, Takeshi Yuasa, Benoit Beuselinck, Aaron Richard Hansen, Neeraj Agarwal, Ziad Bakouny, Daniel Yick Chin Heng, Toni K Choueiri

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

339 Background: The IMDC criteria have been used as a prognostic tool for patients with mRCC receiving single agent VEGF-targeted..

P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs).

Shalini Subramaniam, Guy C Toner, Martin R Stockler, Andrew James Martin, Farzana D Pashankar, Ben Tran, Mark Jeffery, Danish Mazhar, Robert A Huddart, Euan Thomas Walpole, Amanda Gwendolyn Stevanovic, David Wyld, Fritha J Hanning, Matthew James Wheater, Jay R Balagtas, Simon Troon, Alison Jane Birtle, Jeff D White, Peter S Grimison

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

TPS390 Background: Bleomycin, etoposide, and cisplatin (BEP) given 3-weekly x 4 is standard first-line chemotherapy for metastati..

Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.

Shankar Siva, Mathias Bressel, Simon Wood, Mark Shaw, Sherene Loi, Shahneen Kaur Sandhu, Ben Tran, Arun Azad, Jeremy Howard Lewin, Katharine Cuff, Nitika Neha, Duncan Colyer, Paul J Neeson, Howard Liu, Sarat Chander, Daniel Moon, Jeremy Goad, Declan G Murphy, Nathan Lawrentschuk, David Pryor

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

277 Background: Pembrolizumab monotherapy, whilst not standard of care, has demonstrated efficacy in clear cell renal cell carcin..

ICEPAC: A phase II multicenter study of avelumab combined with stereotactic ablative body radiotherapy (SABR) in metastatic castration-resistant prostate cancer (mCRPC)

Arun Azad, Lavinia Anne Spain, Angelyn Anton, Chun Loo Gan, Linda Garrett, Deborah Chang, Caitlin Bennett, Gargi Kothari, Mark Shaw, Phillip Parente, Carmel Jo Pezaro, Ben Tran, Shankar Siva, Edmond Michael Kwan

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

86 Background: Studies investigating immune checkpoint inhibitors (ICI) in mCRPC have produced modest results. Radiation therapy ..

Australia and New Zealand (ANZ) outcomes of high-dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumors (GCT) from 1999 to 2019: Multicenter registry-based study with ABMTRR.

Elizabeth Anne Connolly, Andrew James Weickhardt, Peter S Grimison, Gillian Heller, Jeremy Howard Lewin, Elizabeth Chien Hern Liow, Iris Tung, Ben Tran, Sean Hill, Euan Thomas Walpole, Jane McKenzie, Anna Kuchel, Garry Forgeson, Alvin Boon Tee Tan, Abhishek Joshi, Alistair Wickham, Thean Hsiang Tan, Yang Wang, Nada Hamad, Vanessa Wong

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

382 Background: High dose chemotherapy (HDCT) with autologous stem-cell transplant (ASCT) is effective in advanced germ cell tumo..

Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer

Tahlia Scheinberg, Annabel Goodwin, Emilia Ip, Anthony Linton, Blossom Mak, David P Smith, Martin R Stockler, Madeleine C Strach, Ben Tran, Alison L Young, Alison Y Zhang, Kate L Mahon, Lisa G Horvath

Journal article  |  2021  |  JCO Oncology Practice

PURPOSE: To identify the approximately 12% with inherited cancer predisposition, all men with metastatic prostate cancer (mPC) sho..

A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours

Sunit Sarkar, Ben Tran, Lisa Horvath, Michael Lam, Peter Savas, Peter Grimison, James R Whittle, James C Kuo, Nicole Signal, David Edmonds, Philip Hogg, Danny Rischin, Jayesh Desai, Anne Hamilton

Journal article  |  2021  |  Cancer Chemotherapy and Pharmacology

PURPOSE: This phase I study was conducted to evaluate the safety and Maximum Tolerated Dose of PENAO (4-(N-(S-penicillaminylacetyl..

Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Chun Loo Gan, Shaan Dudani, J Connor Wells, Frede Donskov, Sumanta K Pal, Nazli Dizman, Nityam Rathi, Benoit Beuselinck, Flora Yan, Aly-Khan A Lalani, Aaron Hansen, Bernadett Szabados, Guillermo de Velasco, Ben Tran, Jae Lyun Lee, Ulka N Vaishampayan, Georg A Bjarnason, Mathushan Subasri, Toni K Choueiri, Daniel YC Heng

Journal article  |  2021  |  Cancer Medicine